PROTACs in the Management of Prostate Cancer

PROTACs in the Management of Prostate Cancer

Cancer treatments with targeted therapy have gained immense interest due to their low levels of toxicity and high selectivity. Proteolysis-Targeting Chimeras (PROTACs) have drawn special attention in the development of cancer therapeutics owing to their unique mechanism of action, their ability to t...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Poornachandra Yedla, Ahmed O. Babalghith, Vindhya Vasini Andra, Riyaz Syed
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: MDPI AG 2023-04-01
Cyfres:Molecules
Pynciau:
PROTAC
prostate cancer
androgen receptor
mutation
resistance
Mynediad Ar-lein:https://www.mdpi.com/1420-3049/28/9/3698

Rhyngrwyd

https://www.mdpi.com/1420-3049/28/9/3698

Eitemau Tebyg